RT+AL-HA-Tyr more significantly reduced 18F-FMISO uptake as well as HIF-1α, Ki67, and VEGF-A expression, and increased γ-H2AX expression in tumor cells compared to the other treatments. The gene discussed is H2AX; the disease is neoplasm.